Dental implant component
CA 2336428 A1 · Owner: Astrazeneca Ab · Inventors: Holmen, Anders; Broberg, Leif; Bergstrom, Nils Gustaf
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Dental implant component (1; 1') for a dental prosthesis or a core part of a dental prosthesis to be fabricated on comprising a base section (3; 3') having a proximal end (2; 2') for engagement with a support end of a support component and a distal end (7; 7'); and an elongate post section (5; 5') which projects distally from the distal end of the base section and has a transverse dimension which is substantially less than the transverse dimension of the base section. In a first aspect of the invention the dental implant component is made at least in part from a material which is adapted to burn-out during lost-wax casting whereby a dental prosthesis or core part of a dental …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 21, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 21, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 21, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.